Alkalinization
Analgesics..
Antiandrogens..
Bromhexine
Budesonide
Cannabidiol
Colchicine
Conv. Plasma
Curcumin
Ensovibep
Famotidine
Favipiravir
Fluvoxamine
Hydroxychlor..
Iota-carragee..
Ivermectin
Lactoferrin
Lifestyle..
Melatonin
Metformin
Molnupiravir
Monoclonals..
Nigella Sativa
Nitazoxanide
Nitric Oxide
Paxlovid
Peg.. Lambda
Povidone-Iod..
Quercetin
Remdesivir
Vitamins..
Zinc

Other
Feedback
Home
Home   COVID-19 treatment studies for Ivermectin  COVID-19 treatment studies for Ivermectin  C19 studies: Ivermectin  Ivermectin   Select treatmentSelect treatmentTreatmentsTreatments
Alkalinization Meta Lactoferrin Meta
Melatonin Meta
Bromhexine Meta Metformin Meta
Budesonide Meta Molnupiravir Meta
Cannabidiol Meta
Colchicine Meta Nigella Sativa Meta
Conv. Plasma Meta Nitazoxanide Meta
Curcumin Meta Nitric Oxide Meta
Ensovibep Meta Paxlovid Meta
Famotidine Meta Peg.. Lambda Meta
Favipiravir Meta Povidone-Iod.. Meta
Fluvoxamine Meta Quercetin Meta
Hydroxychlor.. Meta Remdesivir Meta
Iota-carragee.. Meta
Ivermectin Meta Zinc Meta

Other Treatments Global Adoption
All Studies   Meta Analysis   Recent:  
Bayesian Meta Analysis of Ivermectin Effectiveness in Treating Covid-19 Disease
Neil et al., ResearchGate, doi:0.13140/RG.2.2.31800.88323 (Preprint) (meta analysis)
Neil et al., Bayesian Meta Analysis of Ivermectin Effectiveness in Treating Covid-19 Disease, ResearchGate, doi:0.13140/RG.2.2.31800.88323 (Preprint) (meta analysis)
Jul 2021   Source   PDF  
  Twitter
  Facebook
Share
  All Studies   Meta
Bayesian analysis of a subset of ivermectin trial data concluding that there is overwhelming evidence to support a causal link between ivermectin, COVID-19 severity, and mortality.
Currently there are 95 ivermectin studies and meta analysis shows:
OutcomeImprovement
Mortality51% lower [37‑62%]
Ventilation29% lower [13‑42%]
ICU admission41% lower [16‑58%]
Hospitalization34% lower [20‑45%]
Cases78% fewer [67‑85%]
Neil et al., 12 Jul 2021, preprint, 2 authors.
All Studies   Meta Analysis   Submit Updates or Corrections
This PaperIvermectinAll
Abstract: See discussions, stats, and author profiles for this publication at: https://www.researchgate.net/publication/353195913 Bayesian Meta Analysis of Ivermectin Effectiveness in Treating Covid-19 Disease Preprint · July 2021 DOI: 10.13140/RG.2.2.31800.88323 CITATIONS READS 2 25,563 2 authors: Martin Neil Norman Elliott Fenton Queen Mary, University of London Queen Mary, University of London 200 PUBLICATIONS 6,192 CITATIONS 392 PUBLICATIONS 15,653 CITATIONS SEE PROFILE SEE PROFILE Some of the authors of this publication are also working on these related projects: PAMBAYESIAN (PAtient Managed decision-support using Bayesian networks) View project CAUSAL-DYNAMICS ("Improved Understanding of Causal Models in Dynamic Decision-making") View project All content following this page was uploaded by Norman Elliott Fenton on 12 July 2021. The user has requested enhancement of the Bayesian Meta Analysis of Ivermectin Effectiveness in Treating Covid-19 Disease Martin Neil and Norman Fenton Risk Information and Management Research School of Electronic Engineering and Computer Science, Queen Mary University of London 12 July 2021 Abstract A recent peer reviewed meta-analysis evaluating ivermectin (Bryant et al, 2021) concluded that this antiparasitic drug is a cheap and effective treatment for reducing Covid-19 deaths. These conclusions were in stark contrast to those of a later study (Roman et al, 2021). Although (Roman et al, 2021) applied the same classical statistical approach to meta-analysis, and produced similar results based on a subset of the same trials data used by (Bryant et al), they claimed there was insufficient quality of evidence to support the conclusion Ivermectin was effective. This paper applies a Bayesian approach, to a subset of the same trial data, to test several causal hypotheses linking Covid-19 severity and ivermectin to mortality and produce an alternative analysis to the classical approach. Applying diverse alternative analysis methods which reach the same conclusions should increase overall confidence in the result. We show that there is overwhelming evidence to support a causal link between ivermectin, Covid-19 severity and mortality, and: i) for severe Covid-19 there is a 90.7% probability the risk ratio favours ivermectin; ii) for mild/moderate Covid-19 there is an 84.1% probability the risk ratio favours ivermectin. Also, from the Bayesian meta-analysis for patients with severe Covid-19, the mean probability of death without ivermectin treatment is 22.9%, whilst with the application of ivermectin treatment it is 11.7%. The paper also highlights advantages of using Bayesian methods over classical statistical methods for meta-analysis. creative commons license 1
Loading..
Please send us corrections, updates, or comments. Vaccines and treatments are complementary. All practical, effective, and safe means should be used based on risk/benefit analysis. No treatment, vaccine, or intervention is 100% available and effective for all current and future variants. We do not provide medical advice. Before taking any medication, consult a qualified physician who can provide personalized advice and details of risks and benefits based on your medical history and situation. FLCCC and WCH provide treatment protocols.
  or use drag and drop   
Submit